Robert J Benschop

6PUBLICATIONS
30CO-AUTHORS
AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomedicineInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2025
Lebrikizumab Rapidly Lowers Inflammatory Biomarkers with Clinical Correlations in Moderate-to-Severe Atopic Dermatitis.

Emma Guttman-Yassky, Zhe Sun, Laura Rebeca Mena

|Jun 13, 2023
Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab.

Angela J Okragly, Aya Ryuzoji, Isabella Wulur

|Jun 09, 2022
The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination.

Robert J Benschop, Jay L Tuttle, Lin Zhang

|Mar 19, 2022
Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab.

Jonathan T Sims, Josh Poorbaugh, Ching-Yun Chang

|Aug 19, 2021
Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33.

Angela J Okragly, Katie Brannon Corwin, Marikka Elia

|Jun 12, 2019
Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.

Robert J Benschop, Chi-Kin Chow, Yu Tian

Pageof 1

Frequent Collaborators

3 joint publications

Angela Okragly

1 joint publications

Barbra Barmettler

1 joint publications

Shane Atwell

1 joint publications

David Clawson